FIELD: chemistry.
SUBSTANCE: claimed invention relates to compound of formula 1 
inhibiting SGLT2, and to pharmaceutical composition based on it, as well as intermediate compounds.
EFFECT: obtaining novel compounds possessing valuable biologically active properties.
4 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| C-ARYL GLUCOSE SGLT2 INHIBITORS AND METHOD OF THEIR USE | 2020 |
|
RU2800510C1 |
| C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD OF THEIR USE | 2020 |
|
RU2746132C1 |
| PHARMACEUTICAL COMBINATION CONTAINING SGLT2 INHIBITOR | 2008 |
|
RU2489151C2 |
| METHODS FOR SGLT2 INHIBITOR OBTAINING AND APPLICATION | 2013 |
|
RU2643764C2 |
| O-ARYLGLUCOSIDE INHIBITORS OF SGLT2 AND METHOD FOR THEIR USING | 2001 |
|
RU2269540C2 |
| C-ARYLGLUCOSIDE INHIBITORS OF SGLT-2 | 2000 |
|
RU2262507C2 |
| C-PHENYL-1-THIOGLUCITOLS | 2007 |
|
RU2434862C2 |
| COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
| CONDENSED HETEROCYCLIC DERIVATIVES MEDICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL APPLICATION | 2005 |
|
RU2387663C2 |
| BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
